Cargando…

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid

AIMS: Irritability has been described as a frequent adverse event in patients affected by epilepsy and treated with perampanel (PER), levetiracetam (LEV), and less frequently with valproic acid (VPA). Since the questionnaire for irritability (I‐EPI) is a validated instrument to measure this psychiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liguori, Claudio, Turner, Katherine, Izzi, Francesca, Assogna, Martina, Canevini, Maria P., Mercuri, Nicola B., Placidi, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488879/ https://www.ncbi.nlm.nih.gov/pubmed/30675751 http://dx.doi.org/10.1111/cns.13098

Ejemplares similares

Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
por: CHONAN, Masashi, et al.
Publicado: (2020)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
por: Mari, Luisa, et al.
Publicado: (2021)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Add-on perampanel in Lance–Adams syndrome
por: Steinhoff, Bernhard J., et al.
Publicado: (2016)

Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009)

Evaluation of the efficacy and tolerability of levetiracetam as add-on therapy in intractable epilepsy of children
por: Razieh, Razieh, et al.
Publicado: (2022)

Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy
por: Calvello, Carmen, et al.
Publicado: (2023)

Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center
por: Vacca, Mariacarolina, et al.
Publicado: (2021)

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
por: Liguori, Claudio, et al.
Publicado: (2017)

Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
por: Gasparini, Sara, et al.
Publicado: (2022)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)

Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome
por: Kurishima, Akira, et al.
Publicado: (2021)

Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019)

Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
por: Kriechbaumer, Sandra R. P., et al.
Publicado: (2022)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
por: Hansen, Cerine C., et al.
Publicado: (2018)

Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)
por: Coppola, Antonietta, et al.
Publicado: (2020)

Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
por: Nilo, Annacarmen, et al.
Publicado: (2020)

Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy
por: Dreischmeier, Emma, et al.
Publicado: (2021)

The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity
por: Vacca, Mariacarolina, et al.
Publicado: (2023)

Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice
por: Lattanzi, Simona, et al.
Publicado: (2021)

Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017)

Perampanel and Visuospatial Skills in Children With Epilepsy
por: Operto, Francesca Felicia, et al.
Publicado: (2021)

Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
por: MOLLAMOHAMMADI, Mohsen, et al.
Publicado: (2018)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
por: Perversi, Fabio, et al.
Publicado: (2023)

Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2021)

Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
por: Li, Dan, et al.
Publicado: (2022)

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy
por: Wu, Haohao, et al.
Publicado: (2022)

Correction: Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48h04tf6dos9c4eteipav3d6a9